SEMA3A and skin disorder: Experimentally, it has been reported that replacement of recombinant Sema3A in the lesional skin of NC/Nga mice normalized epidermal hyperinnervation, resulting in suppression of itch-related scratching behavior and improved dermatitis [11, 12].